A club that combines racquet sports, fitness amenities, social areas and coworking access is coming to East Hanover as part of a broader redevelopment of the former Novartis corporate campus.

The deal will strengthen Torrent’s presence in the Indian market, as well as facilitate its entry into the fast-growing ...

Since the first-generation CAR-Ts reached the market several years ago, clinicians have become more adept at handling ...

As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense. In the special edition episode from ...

The ADB and PATH report highlights the urgent need for innovative financing models, such as blended finance, impact investing ...

Bengaluru: The U.S. Food and Drug Administration said on Friday had eliminated risk evaluation and mitigation strategies ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

Novartis’ Kymriah (tisagenlecleucel), along with Gilead Sciences’ Tecartus (brexucabtagene autoleucel) and Yescarta (axicabtagene ciloleucel), also stand to benefit from the FDA’s decision. A seventh ...

Taking into account individual holdings, Novartis Ag (NOVN) accounts for about 5.41% of the fund's total assets, followed by Asml Holding Nv (ASML) and Nestle Sa (NESN).

First-in-class monoclonal antibody Omalizumab (Genentech/Novartis) neutralizes free IgE and prevents FcεRI/FcεRII binding. It remains a standard treatment for moderate-to-severe allergic asthma and ...

Pointing to post-KKR acquisitions by JB Chem (such as opthalmology brands from Novartis), Vishal Manchanda, Senior Vice-President (Institutional Research) with Systematix Group, said, they were ...

Felzartamab was originally developed by MorphoSys AG (now MorphoSys GmbH, a Novartis company). Human Immunology Biosciences (HI-Bio) exclusively licensed the rights to develop and commercialize ...